With Cannabis 2.0 fully underway, licensed processors now have the opportunity to begin producing additional classes of cannabis, and to develop new and exciting products to add to their portfolios. […] Read More >>
Health Canada recently revised the cosmetic ingredient hotlist, a science-based document used to communicate known safety concerns associated with cosmetic ingredients. This revision resulted in “cannabis, as defined in subsection […] Read More >>
Update (June 28, 2018): Cannabis is added to Schedule II of the Natural Health Product Regulations. Contact us for further information. 1-866-647-3279 or firstname.lastname@example.org. Update (June 28, 2018): CBD as […] Read More >>
dicentra and all its subsidiaries only provide cannabis consulting services for business conducted in jurisdictions where cannabis is legal (whether for medical use or recreational use or both) on a federal level. We do not provide any consulting services whatsoever for cannabis-related business conducted in the United States of America, or in any of its States or Territories.
Stay abreast of regulatory updates, news, events, offers and more
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.